A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
Clinical trial NCT00236574 · COMPLETED
Trial details
- NCT number
- NCT00236574
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Enrollment
- 974
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.